# Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/oral-poly-adp-ribose-polymerase-inhibitor-olaparib-in-patients-with-brca1-or/

## Facts

| Field | Value |
| --- | --- |
| Author Names | M. William Audeh,James Carmichael,Richard T. Penson,Michael Friedländer,Bethan Powell,Katherine M. Bell‐McGuinn,Clare L. Scott,Jeffrey N. Weitzel,Ana Oaknin,Niklas Loman,Karen H. Lu,Rita K. Schmutzler,Ursula A. Matulonis,Mark Wickens,Andrew Tutt |
| Citations | 2,292 |
| DOI | 10.1016/s0140-6736(10)60893-8 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2110017381 |
| PMID | 20609468 |
| Type | article |
| Year | 2010 |

## Paper authors

- [Michael Friedländer](https://scholariq.org/researchers/michael-friedlander/)

## Paper journal

- [The Lancet](https://scholariq.org/journals/the-lancet/)

## Paper primary topic

- [PARP inhibition in cancer therapy](https://scholariq.org/topics/parp-inhibition-in-cancer-therapy/)

## Paper topics

- [PARP inhibition in cancer therapy](https://scholariq.org/topics/parp-inhibition-in-cancer-therapy/)
- [BRCA gene mutations in cancer](https://scholariq.org/topics/brca-gene-mutations-in-cancer/)
- [Ovarian cancer diagnosis and treatment](https://scholariq.org/topics/ovarian-cancer-diagnosis-and-treatment/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.